The bible of Philippine politics

Tingnan natin kung makatulog ka pa! Admin senators urge Robredo to accept designation as co-chair of anti-drug body

0 486

Allies of the administration in the Senate urge Vice President Leni Robredo Tuesday (November 5) to accept her designation by President Rodrigo Duterte as co-chairperson of the inter-agency body he created to oversee the government’s war on drugs.

Senate President Vicente “Tito” Sotto III said Robredo will finally realize the gravity of the country’s drug problem if she accepts the position offered by Duterte.

“Tanggapin sana para once and for all ma-relaize nila na ang problema ng illegal drugs ay matindi pala, at matigil ang kakasabi nila na itigil na,” he told reporters in a text message.

Sotto said Robredo and her advisers will realize the war on drugs can’t be stopped if she’s given the chance to oversee the administration’s campaign.

“You only would want the war against drugs stopped if you are sympathetic to the drug dealers or at least a user,” he said.

In a memorandum dated October 31, Duterte said Robredo would serve as co-chair of the Inter-Agency Committee on Anti-Illegal Drugs (ICAD) until June 30, 2022, unless sooner revoked.

Malacañang said Robredo will have a Cabinet rank.

Senator Bong Go, Duterte’s former close aide, said Robredo will finally know how hard the President’s job is if she accepts the designation.

“Subukan mo po. At least malalaman mo ang trabaho ng Pangulo at kung gaano kalaki ang problema sa ilegal na droga. Tingnan natin kung makakatulog ka pa,” he said in an interview.

Senator Ronald “Bato” Dela Rosa, a former chief of the Philippine National Police, expressed optimism that the drug war “will become more successful” if Robredo were to be on board.

“I hope we can win this war as one nation undivided by political colors,” he said.

Senator Imee Marcos said Robredo should accept her designation as ICAD co-chair since Duterte needs all the help he can get to go after drug lords.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy